BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19230468)

  • 1. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization.
    Breslow RG; Caiado J; Castells MC
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization for hypersensitivity reactions to medications.
    del Carmen Sancho M; Breslow R; Sloane D; Castells M
    Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
    Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
    J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T; Castells MC
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
    Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
    Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.